{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:02:34Z","timestamp":1790596954731,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Science, Culture and Sports of Japan","doi-asserted-by":"crossref","award":["17390239"],"award-info":[{"award-number":["17390239"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Science, Culture and Sports of Japan","doi-asserted-by":"crossref","award":["21390253"],"award-info":[{"award-number":["21390253"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nippon Boehringer Ingelheim"},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.rmed.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T04:49:57Z","timestamp":1491626997000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Acute bronchodilator responses to \u03b22-agonist and anticholinergic agent in COPD: Their different associations with exacerbation"],"prefix":"10.1016","volume":"127","author":[{"given":"Satoshi","family":"Konno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironi","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoruko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2017.04.005_bib1","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Website]. http:\/\/www.goldcopd.org."},{"key":"10.1016\/j.rmed.2017.04.005_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/thorax.58.8.659","article-title":"Bronchodilator reversibility testing in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2017.04.005_bib3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thx.2006.072777","article-title":"Characterization of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease","volume":"62","author":"Makita","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2017.04.005_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1183\/09031936.00129607","article-title":"Bronchodilator responsiveness in patients with COPD","volume":"31","author":"Tashkin","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2017.04.005_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/arrd.1986.133.1.14","article-title":"Bronchodilator response in chronic obstructive pulmonary disease","volume":"133","author":"Anthonisen","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2017.04.005_bib6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","article-title":"Changes in forced expiratory volume in 1 second over time in COPD","volume":"365","author":"Vestbo","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/09031936.05.00102604","article-title":"Bronchodilator response in the lung health study over 11 yrs","volume":"26","author":"Anthonisen","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2017.04.005_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1164\/ajrccm.159.4.9807121","article-title":"Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease","volume":"159","author":"Hansen","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thoraxjnl-2011-201458","article-title":"Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease","volume":"67","author":"Albert","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2017.04.005_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1378\/chest.93.1.49","article-title":"Reversibility of airway obstruction in relation to prognosis in chronic obstructive pulmonary disease","volume":"93","author":"Kawakami","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.04.005_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1164\/ajrccm\/146.3.555","article-title":"Acute bronchodilator trials in chronic obstructive pulmonary disease","volume":"146","author":"Nisar","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2017.04.005_bib12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1378\/chest.115.4.966","article-title":"The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD","volume":"115","author":"Dorinsky","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.04.005_bib13","first-page":"407","article-title":"Intraindividual variability in maximal expiratory flow-volume and closing volume in asymptomatic subjects","volume":"112","author":"McCarthy","year":"1975","journal-title":"Am. Rev. Repir Dis."},{"key":"10.1016\/j.rmed.2017.04.005_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm.151.2.7842199","article-title":"Spirometry in the lung health study: II. Determinants of short-term intraindividual variability","volume":"151","author":"Enright","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1164\/rccm.201106-0992OC","article-title":"Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease","volume":"185","author":"Nishimura","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FPC.0b013e328349daa1","article-title":"Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to beta2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease","volume":"21","author":"Konno","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.rmed.2017.04.005_bib17","first-page":"1215","article-title":"Spirometry in the lung health study 1","volume":"143","author":"Enright","year":"1991","journal-title":"Method Qual. Control"},{"key":"10.1016\/j.rmed.2017.04.005_bib18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2017.04.005_bib19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1183\/09031936.00110213","article-title":"Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study","volume":"43","author":"Suzuki","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2017.04.005_bib20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","article-title":"Asthma-like features and clinical course of COPD: an analysis from the Hokkaido COPD cohort study","volume":"194","author":"Suzuki","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1378\/chest.13-0622","article-title":"Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype COPD-Asthma","volume":"145","author":"Menezes","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.04.005_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1378\/chest.15-1055","article-title":"Defining the Asthma-COPD overlap syndrome in a COPD cohort","volume":"149","author":"Cosio","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.04.005_bib23","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMra1411863","article-title":"The Asthma-COPD overlap syndrome","volume":"373","author":"Postma","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-2600(15)00254-4","article-title":"The asthma\u2013COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?","volume":"3","author":"Bateman","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2017.04.005_bib26","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2017.04.005_bib27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","article-title":"Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis","volume":"158","author":"Pizzichini","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.115.3.697","article-title":"Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema","volume":"115","author":"Fujimoto","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.04.005_bib29","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomized controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2017.04.005_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(13)70158-9","article-title":"Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomized, blinded, parallel-group study","volume":"1","author":"Decramer","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2016.02.012","article-title":"Effect of tiotropium on COPD exacerbations: a systematic review","volume":"114","author":"Halpin","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2017.04.005_bib34","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"Lung function testing: selection of reference values and interpretative strategies","volume":"144","author":"American Thoracic Society","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2017.04.005_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-12-6","article-title":"Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial","volume":"12","author":"Hanania","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2017.04.005_bib36","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease (COPD)","volume":"8","author":"Siafakas","year":"1995","journal-title":"Eur. Respir. J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117301075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117301075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:36:23Z","timestamp":1760614583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117301075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":36,"alternative-id":["S0954611117301075"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.04.005","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute bronchodilator responses to \u03b22-agonist and anticholinergic agent in COPD: Their different associations with exacerbation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}